| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/23/1998 | CN1039908C Tricyclic diazepine vasopressin antagonists |
| 09/22/1998 | US5811553 Quinoline derivatives(2) |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/22/1998 | US5811426 Urea and thiourea derivatives of azolones |
| 09/22/1998 | US5811392 Conformationally constrained backbone cyclized peptide analogs |
| 09/22/1998 | US5811388 Delivery of drugs to the lower GI tract |
| 09/22/1998 | US5811237 Sequence coding for protein expressed by campylobacter pylori |
| 09/22/1998 | US5811123 Method of treating mucosal tissue |
| 09/22/1998 | CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |
| 09/22/1998 | CA2086434C Quinuclidine derivatives |
| 09/17/1998 | WO1998040486A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040406A1 Calcium phosphopeptide complexes |
| 09/17/1998 | WO1998040386A1 Dioxino derivatives and their use as therapeutic agents |
| 09/17/1998 | WO1998040370A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040364A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040097A2 Bovine respiratory and enteric coronavirus as a vaccine |
| 09/17/1998 | WO1998040069A2 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040064A1 Butyrate prodrugs derived from lactic acid |
| 09/17/1998 | WO1998040054A1 An enteric coated oral dosage form comprising sodium amoxycillin |
| 09/17/1998 | WO1998040047A1 Agents for promoting oral hygiene and oral health |
| 09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19710068A1 Mittel zur Förderung der Mundhygiene und der Mundgesundheit Means of promoting oral hygiene and oral health |
| 09/17/1998 | CA2727634A1 Calcium fluoride phosphate complexes |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2282710A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | CA2282349A1 Lta4 hydrolase inhibitors |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864582A2 Hypolipidemic 1,4-benzothiazepine-1,-dioxides |
| 09/16/1998 | EP0864579A2 Bismuth salts of moenomycin-like antibiotics, preparation, use and pharmaceuticals containing such salts |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863767A2 Powdery iodine complexes |
| 09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 09/16/1998 | EP0863752A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 09/16/1998 | EP0728128B1 Substituted phenyl compounds |
| 09/16/1998 | EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 09/16/1998 | EP0708640B1 Pharmaceutical preparations with an active principle containing modified amidin groups |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193274A Calcium-ion channel antagonists |
| 09/16/1998 | CN1193017A Sulfamide-substituted condensed seven-membered ring chemical compound, use as medicine and medicinal preparation containing same |
| 09/16/1998 | CN1192924A Health-care inhalant of loguat leaf and preparation method therefor |
| 09/16/1998 | CN1192922A Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5807890 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807867 Quinuclidine derivatives |
| 09/15/1998 | US5807833 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | CA2146414C Treatment of h. pylori infections |
| 09/15/1998 | CA2001750C Pyrrolidine derivatives |
| 09/11/1998 | WO1998039463A2 Lentivirus based vector and vector system |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039296A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998039030A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | WO1998039011A1 Photosensitizer conjugates for pathogen targeting |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998029095A3 Sustained release cisapride mini-tablet formulation |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2283076A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | CA2277839A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use |
| 09/11/1998 | CA2231365A1 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts |
| 09/10/1998 | CA2231591A1 Bovine respiratory coronavirus |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0862919A1 Remedy for hepatitides |
| 09/09/1998 | EP0862631A1 Luminal cholecystokinin-releasing factor |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
| 09/09/1998 | EP0862461A1 Methods of treating established colitis using antibodies against il-12 |
| 09/09/1998 | EP0862439A1 Ligands to enhance cellular uptake of biomolecules |
| 09/09/1998 | EP0617620B1 Use of 5-ht4 - antagonists for the manufacture of a medicament for the treatment of urinary incontinence |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1192681A Novel medical use |
| 09/09/1998 | CN1192375A Traditional Chinese medicinal powder for treating oral disease, and method for preparing same |
| 09/09/1998 | CN1192360A Medicinal prepn. contg. beneficial bacteria named 'Junyikang' and method for preparing same |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804589 Treatment of pain; irritable bowel syndrome |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804549 Glycerol monolaurate, nisin in the absence of a chelator and a carrier |
| 09/08/1998 | US5804376 Nucleotide and amino acid sequences; expression vector; genetically engineered host cells; diagnostic tests |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |